Their only hope is an Innoventure deal, or less convincingly to many a CellHeal deal. They announced a $10mill fund with CellHeal last year prematurely.
Leong is clearly useless at raising capital in Singapore as others have pointed out. Suspect a lot of this is poorly executed attempts to tie the company over until deals, or a last swan dive. Who knows?
Ann: Prospectus for Renounceable Rights Issue, page-11
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
